We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
4d Pharma Plc | LSE:DDDD | London | Ordinary Share | GB00BJL5BR07 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.36 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/10/2020 16:33 | Closed high of the day. Expect some more gains tomorrow. So oversold anyway and 110/111p was key resistance. | showmethemoneyhoney01 | |
22/10/2020 16:32 | Price predictions short term? | tomv33 | |
22/10/2020 16:29 | It's good the Directors are so tenacious. They did not flinch down at 35p and had another £500ks worth. They used the Woodford selling to their advantage. Now they have shown confidence again after the IBS sell-off and done the NAS deal and ponied up more cash. I like it. There is real belief from them. They know far more about DDDD than all of us put together. It is a good sign. | 1airbag | |
22/10/2020 16:26 | Mini Bowl --》 175p for starters! ;@) | gymratt | |
22/10/2020 16:23 | Todays news and rise in the share price will put us back on the map again. We needed it after the last two weeks , lol ! | thepaddedcell | |
22/10/2020 16:23 | Duncan is saying and doing all the right things about the valuation of 4D vs "peers" valued at $2Bn... | yoda5442 | |
22/10/2020 16:18 | I don't know whether this has already been posted but in case it hasn't - below is link to an excellent interview with Duncan Peyton and great coverage for DDDD. | bermudashorts | |
22/10/2020 16:18 | 116p close...... and 125p tomorrow | christh | |
22/10/2020 16:16 | Must be the final shorts closing. | katsy | |
22/10/2020 16:16 | Up over 20%, good old days are back, here's to plenty more and hoping the 3 speechs between 9th-14th November takes us back above recent highs. | mickinvest | |
22/10/2020 16:15 | Nice to have got the chance to load up below | volsung | |
22/10/2020 16:12 | IG Have stopped trading DDDD. | 1airbag | |
22/10/2020 16:05 | We're on the move again. | 1airbag | |
22/10/2020 16:00 | C'mon yer b*stards let it rip! | blueblood | |
22/10/2020 15:59 | No wonder Griffiths was increasing holding again recently. | blueblood | |
22/10/2020 15:44 | He does already know the data they're presenting at #SITC2020 and he'll be aware of which execs from Bristol-Myers, Roche, Pfizer etc are suddenly wanting to arrange meetings with him | the stigologist | |
22/10/2020 15:40 | Love this from Duncan - "...Frankly, I don't know of a more exciting company" | someuwin | |
22/10/2020 15:31 | Nearly 9 million volume and the share price has been stuck on 1.08 all day like a broken needle ! Exactly why they are sacking off aim for Nasdaq! | bernieman | |
22/10/2020 15:29 | Judging by the continued manipulation, no wonder we are moving away from AIM! MRX0518 is going to be very interesting, they wouldn't even consider a nasdaq listing if they thought their results were going to be bad. Roll on January! The bots wont have it their way then, you can't stop arbitrageurs, not even a bot can do that! | devonlad | |
22/10/2020 15:24 | INCREDIBLE podcast Paraphrasing "Comps valued at £2bn+ and we're the World Leader" "More importantly we'll have data on MRx0518 MONOTHERAPY" Strap in folks :-D | the stigologist | |
22/10/2020 15:21 | Fantastic podcast 4d pharma ceo | sharif1987 | |
22/10/2020 15:21 | https://audioboom.co | sharif1987 | |
22/10/2020 15:21 | https://audioboom.co | sharif1987 | |
22/10/2020 15:14 | EEZA, rushing and slowly in the same sentence, WTF. | 1airbag | |
22/10/2020 15:12 | Yanks rushing to buy, slowly. | eeza |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions